Fundraising FoxIntuitive Biosciences
Middleton, US · Founded 2012 · Wisconsin corporation
Find your way into Intuitive Biosciences
Sign up to see every warm intro you have to Intuitive Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intuitive Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Intuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
Founders & leadership
KL
Kimberly LukeVice President of Research and DevelopmentVice President of Research and Development at Intuitive Biosciences, Kimberly Luke leads product development and research initiatives focused on diagnostic assays for infectious disease detection. Her background includes expertise in immunoassay platform development, in vitro diagnostic development, and work on biomarker research including extracellular vesicle characterization.
JB
JR
Jason R. SmithNamed on SEC filing
Board
HN
Harald NordalBoard director
CE
Craig E SmithBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 3 rounds · 2014–2019
▶$1.2MraisedOct 2019 · 5 investors · BiotechnologyRule 506(b)
▶$1.2MraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig SmithDirector
- Jason R SmithDirector
- Johan MichelsenDirector
- Shawn D GuseExecutive Officer, Director
- Jay SekelskyDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Sep 2019
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$1.3MraisedJun 2015 · 5 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJun 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harald NordalDirector
- Craig E SmithDirector
- Jason R SmithDirector
- Shawn D GuseExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $1.3M
- First sale
- May 2015
- Incorporated
- Corporation, Wisconsin, 2012
- Federal exemptions
- 06b
▶$486.9KraisedAug 2014 · 5 investors · BiotechnologyRule 506(b)
▶$486.9KraisedAug 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig SmithDirector
- Jason R. SmithDirector
- Harald NordalExecutive Officer, Director
- Shawn D GuseExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $486.9K
- First sale
- Aug 2014
- Incorporated
- Corporation, Wisconsin, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Life BiosciencesLife Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.
Twist BioscienceTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.
Companies working in the same space as Intuitive Biosciences.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $306.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $299.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Intuitive Biosciences do?
- Intuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
- How much funding has Intuitive Biosciences raised?
- Intuitive Biosciences has disclosed $3M raised across 3 rounds.
- Where is Intuitive Biosciences headquartered?
- Intuitive Biosciences is headquartered in Middleton, US.